Package Leaflet: Information for the User
Venlafaxine Retard Qualigen 75 mg prolonged-release hard capsulesEFG
Venlafaxine Retard Qualigen contains the active substance venlafaxine.
Venlafaxine Retard Qualigen is an antidepressant that belongs to a group of medicines called serotonin and norepinephrine reuptake inhibitors (SNRIs). This group of medicines is used to treat depression and other conditions such as anxiety disorders. It is not fully understood how antidepressants work, but they may help to increase the levels of serotonin and norepinephrine in the brain.
Venlafaxine Retard Qualigen is a treatment for adults with depression. It is also a treatment for adults with the following anxiety disorders: social anxiety disorder (fear or avoidance of social situations), generalized anxiety disorder, and panic disorder. Treating depressive and anxiety disorders properly is important to help you feel better. If left untreated, your condition may not improve or may get worse and become more difficult to treat.
If you are also taking, or have taken within the last 14 days, any medicines known as irreversible monoamine oxidase inhibitors (MAOIs) used to treat depression or Parkinson's disease. Taking an irreversible MAOI with Venlafaxine Retard Qualigen can cause serious or even life-threatening side effects. Also, you must wait at least 7 days after you stop taking Venlafaxine Retard Qualigen before you can take any irreversible MAOI (see also the section “Taking Venlafaxine Retard Qualigen with other medicines” and the information in that section about “Serotonin syndrome”).
Consult your doctor or pharmacist before you start taking Venlafaxine Retard Qualigen:
Venlafaxine Retard Qualigen may cause a feeling of restlessness or difficulty sitting or standing still during the first few weeks of treatment. You should consult your doctor if this happens to you.
Do not drink alcohol while you are taking Venlafaxine Retard Qualigen, as it may cause extreme drowsiness and unconsciousness. Concomitant use with alcohol and/or certain medicines may worsen your symptoms of depression and other conditions, such as anxiety disorders.
If you are depressed and/or have an anxiety disorder, you may sometimes have thoughts of harming or killing yourself. These thoughts may increase when you first start taking antidepressants, because all these medicines take time to work, usually around about two weeks but sometimes longer. These thoughts may also occur when your dose is reduced or when you stop taking venlafaxine.
This is more likely to happen:
If you have thoughts of harming or killing yourself at any time, contact your doctor or go to hospital straight away.
You may find it helpful to tell a relative or close friend that you are depressed or have an anxiety disorder and ask them to read this leaflet. You might ask them to tell you if they think your depression or anxiety is getting worse, or if they are worried about changes in your behavior.
Dry mouth
Dry mouth has been reported in 10% of patients treated with venlafaxine. This may increase the risk of tooth decay (caries). Therefore, you should be careful with your dental hygiene.
Diabetes
Your blood glucose levels may be altered due to Venlafaxine Retard Qualigen. Consequently, it may be necessary to adjust the dose of your diabetes medication.
Sexual problems
Some medicines of the same group as Venlafaxine Retard Qualigen (called SNRIs) may cause symptoms of sexual dysfunction (see section 4). In some cases, these symptoms have persisted after stopping treatment.
Venlafaxine Retard Qualigen should not normally be used in the treatment of children and adolescents under 18 years of age. Also, you should know that in patients under 18 years of age, there is an increased risk of side effects such as suicide attempts, suicidal thoughts, and hostility (predominantly aggression, confrontation, and irritability) when they take this type of medicine. Nevertheless, your doctor may prescribe this medicine to patients under 18 years of age when he decides that it is the best option for the patient. If your doctor has prescribed this medicine to a patient under 18 years of age and you want to discuss this decision, please go back to your doctor. You should inform your doctor if any of the above symptoms develop or worsen when these patients under 18 years of age are taking Venlafaxine Retard Qualigen. Also, the long-term safety of this medicine in this age group concerning growth, maturation, and cognitive and behavioral development has not been demonstrated.
Tell your doctor or pharmacist if you are using, have recently used, or might use other medicines.
Your doctor will decide whether you can take Venlafaxine Retard Qualigen with other medicines.
Do not start or stop taking any medicines, including those bought without a prescription, herbal or plant-based remedies, before checking with your doctor or pharmacist.
A potentially life-threatening condition, or reactions similar to Neuroleptic Malignant Syndrome (NMS) (see section “Possible side effects”), may occur with venlafaxine treatment, particularly when taken with other medicines.
Examples of these medicines include:
The signs and symptoms of serotonin syndrome may include a combination of the following:
restlessness, hallucinations, loss of coordination, rapid heartbeat, increased body temperature, rapid changes in blood pressure, overactive reflexes, diarrhea, coma, nausea, vomiting. In its most severe form, serotonin syndrome can resemble Neuroleptic Malignant Syndrome (NMS). The signs and symptoms of NMS may include a combination of fever, rapid heartbeat, sweating, severe muscle stiffness, confusion, increased muscle enzymes (determined by a blood test).
Tell your doctor immediately or go to the hospital emergency department if you think you are experiencing serotonin syndrome.
Tell your doctor if you are taking medicines that may affect your heart rhythm.
Some examples of these medicines include:
The following medicines may also interact with Venlafaxine Retard Qualigen and should be used with caution. It is especially important to mention to your doctor or pharmacist if you are taking medicines containing:
Venlafaxine Retard Qualigen should be taken with food (see section 3 “HOW TO TAKE VENLAFAXINE RETARD QUALIGEN”).
Do not drink alcohol while you are taking Venlafaxine Retard Qualigen. Concomitant use with alcohol may cause extreme drowsiness and unconsciousness and may worsen your symptoms of depression and other conditions, such as anxiety disorders.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
You should only take Venlafaxine Retard Qualigen after discussing the potential benefits and risks with your doctor. When similar medicines (SSRIs) are taken during pregnancy, they may increase the risk of a serious condition in babies, called persistent pulmonary hypertension in newborns (PPHN), which makes the baby breathe faster and have a bluish appearance. These symptoms usually appear during the first 24 hours after the baby is born. If this happens to your baby, you should contact your midwife and/or doctor immediately.
If you are taking this medicine during pregnancy, in addition to breathing problems, another symptom your baby may have when born is problems with feeding. If your baby has these symptoms when born and you are concerned, contact your doctor and/or midwife, who will be able to advise you.
If you take Venlafaxine Retard Qualigen in the final stages of pregnancy, you may have a higher risk of heavy vaginal bleeding after giving birth, especially if you have a history of bleeding disorders. Your doctor or midwife should know that you are taking Venlafaxine Retard Qualigen so they can advise you.
Venlafaxine Retard Qualigen passes into breast milk. There is a risk of an effect on the baby. Therefore, you should discuss this with your doctor, and he will decide whether you should stop breastfeeding or stop taking this medicine.
Do not drive or use tools or machines until you know how this medicine affects you.
Venlafaxine Retard Qualigen contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per capsule; this is essentially “sodium-free”.
Take Venlafaxine Retard Qualigen exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
The usual recommended starting dose for the treatment of depression, generalized anxiety disorder, and social anxiety disorder is 75 mg per day. Your doctor may gradually increase the dose and, if necessary, up to a maximum of 375 mg per day for depression. If you are being treated for panic disorder, your doctor will start you on a lower dose (37.5 mg) and then gradually increase the dose. The maximum dose for generalized anxiety disorder, social anxiety disorder, and panic disorder is 225 mg/day.
Take Venlafaxine Retard Qualigen at approximately the same time each day, either in the morning or in the evening. The capsules should be swallowed whole with liquids and should not be opened, crushed, chewed, or dissolved.
Venlafaxine Retard Qualigen should be taken with food.
If you have liver or kidney problems, talk to your doctor, as you may need a different dose of this medicine. Do not stop taking this medicine without talking to your doctor (see section “If you stop taking Venlafaxine Retard Qualigen”).
Call your doctor or pharmacist immediately if you take more of this medicine than your doctor prescribed. You can also contact the Poison Information Service, telephone 91 562 04 20, stating the medicine and the amount taken.
Overdose can be life-threatening, especially when taken with alcohol and/or certain medicines (see “Other medicines and Venlafaxine Retard Qualigen”).
Symptoms of a possible overdose may include palpitations, changes in the level of consciousness (ranging from drowsiness to coma), blurred vision, seizures or fits, and vomiting.
If you miss a dose, take it as soon as you remember. However, if it is already time for your next dose, skip the missed dose and take only a single dose as usual. Do not take a double dose to make up for forgotten doses. Do not take more than the daily dose of Venlafaxine Retard Qualigen that your doctor has prescribed in one day.
Do not stop taking your treatment or reduce the dose without the advice of your doctor, even if you feel better. If your doctor thinks you no longer need Venlafaxine Retard Qualigen, he may ask you to reduce the dose gradually before stopping treatment completely. It is known that side effects occur when people stop using this medicine, especially when it is stopped suddenly or the dose is reduced too quickly. Some patients may experience symptoms such as suicidal thoughts, aggression, tiredness, dizziness, unsteadiness, headache, insomnia, nightmares, dry mouth, loss of appetite, nausea, diarrhea, nervousness, agitation, confusion, ringing in the ears, tingling, or, in rare cases, sensations of electric shock, weakness, sweating, seizures, or symptoms similar to flu, vision problems, and increased blood pressure (which can cause headache, dizziness, ringing in the ears, sweating, etc.).
Your doctor will advise you how to gradually stop taking Venlafaxine Retard Qualigen. This may take several weeks or months. In some patients, the discontinuation may need to be very gradual over several months or longer. If you experience any of these or other symptoms that are troublesome, consult your doctor for further advice.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
If any of the following effects occur, do not take more Venlafaxina Retard Qualigen. Tell your doctor immediately, or go to the emergency department of the nearest hospital:
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
In its most severe form, serotonin syndrome can resemble neuroleptic malignant syndrome (NMS). The signs and symptoms of NMS may include a combination of fever, rapid heartbeat, sweating, severe muscle stiffness, confusion, increased muscle enzyme levels (determined by a blood test).
Frequency not known (cannot be estimated from the available data)
Other adverse effects that you should report to your doctorare (the frequency of these adverse effects is included in the list below "other adverse effects that may occur"):
Other adverse effects that may occur
Very common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Very rare (may affect up to 1 in 10,000 people)
Frequency not known (cannot be estimated from the available data)
Venlafaxina Retard Qualigen sometimes produces unwanted effects that you may not be aware of, such as increased blood pressure or abnormal heartbeat; mild changes in blood liver enzyme, sodium or cholesterol levels. Less frequently, Venlafaxina Retard Qualigen may reduce the function of blood platelets, leading to an increased risk of bruising or bleeding. Therefore, your doctor may want to perform occasional blood tests, especially if you have been taking Venlafaxina Retard Qualigen for a long time.
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor, pharmacist or nurse, even if it is a possible adverse effect that is not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: http://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep out of sight and reach of children.
Do not use this medicine after the expiration date that appears on the box and blister, after CAD. The expiration date is the last day of the month indicated.
Do not store above 30°C.
Medicines should not be disposed of through wastewater or household waste. Deposit the containers and medicines you no longer need in the Sigre Point of the pharmacy. In case of doubt, ask your pharmacist how to dispose of the containers and medicines you no longer need. This way, you will help protect the environment.
The active ingredient is venlafaxine.
Each prolonged-release capsule contains 75 mg of venlafaxine as venlafaxine hydrochloride.
The other ingredients are:
Capsule content:hypromellose, ammonio methacrylate copolymer (type B), sodium lauryl sulfate (E487), magnesium stearate.
Coating:butylated methacrylic acid copolymer 12.5%,
Capsule:gelatin, titanium dioxide (E171), red iron oxide (E 172),
Printing ink:Shellac, black iron oxide (E172), propylene glycol (E1520).
Venlafaxina Retard Qualigen 75 mg hard prolonged-release capsules: hard gelatin capsules of opaque flesh color (size 0) containing two film-coated round and biconvex tablets, serigraphed VEN on the cap and 75 on the body.
Packages containing 28, 30 or 98 capsules.
Only some package sizes may be marketed.
Neuraxpharm Spain, S.L.U.
Avda. Barcelona, 69
08970 Sant Joan Despí
Barcelona - Spain
Manufacturer
Pharmathen, S.A.
6, Dervenakion Str. – GR – 15351
(Pallini. Attikis) Greece
O
Pharmathen International S.A.
Sapes Industrial Park
Block 5, 69300 Rodopi
Greece
O
Neuraxpharm Pharmaceuticals, S.L.
Avda. Barcelona, 69
08970 Sant Joan Despí
Barcelona - Spain
Date of the last revision of this leaflet:June 2024
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.
The average price of VENLAFAXINE RETARD QUALIGEN 75 mg PROLONGED-RELEASE HARD CAPSULES in October, 2025 is around 9.59 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.